| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
ritterazine B
1
relevant articles (0 outcomes,
1 trials/studies)
found for this Bio-Agent
Description: ritterazine analog extracted from Ritterella tokioka, has been shown to be chemically similar to cephalostatin 1; structure in first source
Bio-Agent Context: Research Results
Experts
| 1. | Kaye, Frederic J: 1 article (03/2003) |
| 2. | Tamura, Kenji: 1 article (03/2003) |
| 3. | Komiya, Takefumi: 1 article (03/2003) |
| 4. | Kubo, Akihito: 1 article (03/2003) |
| 5. | Kelley, Michael J: 1 article (03/2003) |
| 6. | Matsunaga, Shigeki: 1 article (03/2003) |
| 7. | Fukuoka, Masahiro: 1 article (03/2003) |
| 8. | Yoshida, Makoto: 1 article (03/2003) |
| 9. | Nakagawa, Kazuhiko: 1 article (03/2003) |
| 10. | Fusetani, Nobuhiro: 1 article (03/2003) |
Related Diseases
| 1. | Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/01/2003
- "The objective of this study was to determine the cytotoxicity of ritterazine B to non-small-cell lung cancer (NSCLC) cells in vitro and its effects on the cell cycle and apoptosis. "
Order ALL the reference details at left... |
| 2. | Neoplasms (Cancer)
03/01/2003
- "Ritterazine B, a new cytotoxic natural compound, induces apoptosis in cancer cells."
Order ALL the reference details at left... |
| 3. | Leukemia
03/01/2003
- "PURPOSE: Ritterazine B, one of the ritterazine analogues extracted from Ritterella tokioka, has been shown to be chemically similar to cephalostatin 1, and among the ritterazine derivatives is the most cytotoxic to P388 murine leukemia cells. "
Order ALL the reference details at left... |
Related Drugs and Biologics
| 1. | cephalostatin I
|
Best Treatments:
Research Summary Report
on Small Cell Lung Carcinoma
Research Summary Report
on Small Cell Lung Carcinoma
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
- Free Updates for 1 Year
- All 1101 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Reference Details
- Sample PDF Report on Psoriasis >>
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License Details >>
| Price: | $490.00
access via web interface 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |